Search

everythinglearnresearchcommunity

for

Search:↓

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

The androgen receptor gene doesn't affect women with recurrent spontaneous abortions, but having a mutant genotype might protect against it.

DHT enhances androgen receptor activity more than testosterone, and MAGE-11 influences this activity through specific interactions.

A 12-year-old boy with PAIS successfully developed male characteristics using high-dose testosterone and anastrozole.

Androgen receptor overexpression can increase prostate cancer cell growth even without hormones.

Increased androgen receptor expression in certain hair follicle areas may cause male pattern baldness.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

SARMs work differently in tissues due to unique interactions and structures.

A new treatment for hair loss shows promise with fewer side effects.

A new hair loss treatment using dissolving microneedles was found to speed up hair growth and was more effective than daily use of common hair growth drugs.

The number of CAG repeats in the androgen receptor gene doesn't significantly affect female pattern hair loss in the Han Chinese population.

Androgen receptor differences may contribute to hair loss in AGA patients.

Certain gene variations are significantly linked to hair loss, especially in white people.

Gene variation affects prostate issues and hair loss.

Shorter GGN repeats in the androgen receptor gene are linked to androgenetic alopecia.

The androgen receptor gene doesn't help identify women likely to have female pattern hair loss.

CAG repeat numbers in the AR gene likely don't affect hair loss in Korean men.

A genetic test can identify people at risk of male pattern baldness early, allowing for quicker treatment.

Shorter GGC triplet repeats in the androgen receptor gene are linked to less hair loss in Han men.

Androgen receptor abnormalities may contribute to hair loss in androgenetic alopecia.

Combining RU58841 and minoxidil significantly increases hair growth.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Different types of androgens bind differently to two receptors, AR1 and AR2, in Atlantic croaker's brain and ovarian tissues, suggesting these receptors may control different androgen actions in fish.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

Alopecia areata involves specific T-cells, unlike androgenetic alopecia.

Topical latanoprost acid at 0.05% concentration improved hair growth in women with androgenetic alopecia.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.